Anticoagulation in Cerebral Venous Thrombosis Complicated By Intracranial Hemorrhage: A Case Report and Clinical Review

Authors

  • Dr Rishabh Dev Shukla
  • Dr. Arun K
  • Dr. Mathisha Ebby Perin
  • Dr. Balaji N
  • Dr Sreeniddhi V
  • Dr Arun Kumar CM
  • Dr Arun Solanki

DOI:

https://doi.org/10.67440/ahj.vi.3319

Keywords:

cerebral venous thrombosis; intracranial hemorrhage; anticoagulation; low-molecular-weight heparin; direct oral anticoagulants; venous stroke.

Abstract

Background: Cerebral venous thrombosis (CVT) is an uncommon cause of stroke in which a clot blocks a cerebral vein or dural sinus. Haemorrhagic venous infarction or intracerebral haematoma is found in a substantial minority of patients at presentation. Because heparin is the cornerstone of treatment, bleeding on the admission scan creates an apparent dilemma between treating the clot and risking haematoma growth.

Case:

A 32-year-old woman taking a combined oral contraceptive, presented with five days of progressive headache followed by a focal seizure. CT showed a right fronto-parietal haemorrhage of about 28 mL, and MR venography showed thrombosis of the superior sagittal sinus and right transverse sinus. Therapeutic enoxaparin was started within 12 hours of admission after a stable 24-hour repeat CT, levetiracetam was added, and dabigatran replaced the heparin on day 7. The haematoma shrank to about 18 mL by day 6 with no new bleeding; the patient reached mRS 0 at six months, with partial recanalisation of the sagittal sinus and complete reopening of the right transverse sinus.

Review: Randomised and observational evidence was reviewed from guideline documents, a Cochrane review, two small heparin trials, the RE-SPECT CVT randomised trial, the ACTION-CVT registry and a 2024 meta-analysis of DOAC versus warfarin. Current European and American guidance supports therapeutic anticoagulation even when haemorrhage is present, with heparin in the acute phase and oral therapy afterwards, and with decompressive surgery reserved for impending herniation.

Conclusion: Haemorrhage on the initial scan is not by itself a reason to withhold anticoagulation in CVT. Treatment should be started early, monitored with close neurological and imaging surveillance, and individualised by bleeding risk, cause of the thrombosis and the patient's response.

Downloads

Published

2026-11-16

How to Cite

Shukla, D. R. D., K, D. A., Perin, D. M. E., N, D. B., V, D. S., CM, D. A. K., & Solanki, D. A. (2026). Anticoagulation in Cerebral Venous Thrombosis Complicated By Intracranial Hemorrhage: A Case Report and Clinical Review. Adolescência E Saúde, 446–454. https://doi.org/10.67440/ahj.vi.3319

Issue

Section

Original Articles